Synthesis and In Vitro/In silico Evaluation of Novel 2‑Aryl-6-carboxamide-Substituted Benzoxazole Derivatives with Anticancer Effects and mTOR Inhibitory Potential
Ceylan Hepokur, Okan Aykaç, Sema Misir, Şeyda Akin, Burak Kuzu, Naveen Kosar, Recep Kurnaz, Öztekin Algül · 2026
Read Synthesis and In Vitro/In silico Evaluation of Novel 2‑Aryl-6-carboxamide-Substituted Benzoxazole Derivatives with Anticancer Effects and mTOR Inhibitory Potential by Ceylan Hepokur, Okan Aykaç, Sema Misir, Şeyda Akin, Burak Kuzu, Naveen Kosar, Recep Kurnaz, Öztekin Algül (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13261455.txt.
Description
Ceylan Hepokur and seven co-authors made new benzoxazole compounds in two thousand twenty-six and tested them against breast cancer cells. They aimed at a growth switch called mTOR, a common drug target. The compounds were built in three steps and checked by nuclear magnetic resonance, then modelled on computers for binding and drug-like traits.
Two compounds stood out in tests on two breast cancer cell lines, with one line more sensitive. They triggered cell death signals, shifted key gene activity, and halted the cell cycle at set phases. Computer models backed the mTOR link. The authors present the pair as leads for further cancer drug work.
Catalog record
| CREATOR | Ceylan Hepokur, Okan Aykaç, Sema Misir, Şeyda Akin, Burak Kuzu, Naveen Kosar, Recep Kurnaz, Öztekin Algül |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 83 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |